{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:51:16Z","timestamp":1790736676787,"version":"4.1.0"},"reference-count":64,"publisher":"American Chemical Society (ACS)","issue":"15","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/na","name":"National Recovery and Resilience Plan (NRRP), Mission 04 Component 2 Investment 1.5?NextGenerationEU","doi-asserted-by":"publisher","award":["0001052"],"award-info":[{"award-number":["0001052"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"University of Padova","doi-asserted-by":"publisher","award":["DOR"],"award-info":[{"award-number":["DOR"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"University of Ferrara","doi-asserted-by":"publisher","award":["FAR"],"award-info":[{"award-number":["FAR"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"ItelPharma","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Italian Ministry of University","doi-asserted-by":"publisher","award":["P20225HP4C"],"award-info":[{"award-number":["P20225HP4C"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The nociceptin\/orphanin FQ (N\/OFQ) receptor (NOP) ligands are drug candidates for different diseases, but peptide ligands are often limited by rapid enzymatic degradation and short in vivo duration of action. Here, we applied a multiple D-amino acid substitution strategy to the peptide template [Arg14 Lys15]N\/OFQ(1-15)-NH2 to improve metabolic stability while preserving receptor activity. Progressive substitutions revealed marked positional tolerance within the C-terminal address domain and identified [d-Lys13,15d-Arg14]N\/OFQ(1\u201315)-NH2 (compound 1c) as the most promising compound. This led to the Cha1-containing analogue 3a, which retained full agonist efficacy and high selectivity at the NOP receptor in vitro and ex vivo. In vivo, compound 3a induced a long-lasting loss of the righting reflex in mice, closely overlapping the pharmacological profile of the potent and long-acting agonist UFP-112. These findings define the stereochemical tolerance of the NOP receptor toward multiple d-amino acid substitutions within the N\/OFQ peptide and demonstrate that this information can be exploited as a rational design strategy to generate NOP receptor agonists with prolonged in vivo activity.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01281","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:29:39Z","timestamp":1784827779000},"page":"18977-18991","source":"Crossref","is-referenced-by-count":1,"title":["Design of New\nPotent, Selective, and Long-Acting NOP\nReceptor Agonists through Multiple Sequential\n                    <scp>d<\/scp>\n                    -Amino\nAcid Substitutions of [Arg14 Lys15]N\/OFQ(1\u201315)-NH2"],"prefix":"10.1021","volume":"69","author":[{"given":"Chiara","family":"Sturaro","sequence":"first","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Rizzo","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Morrone","sequence":"additional","affiliation":[{"name":"University of Padova , , Largo Meneghetti, 2 , ,","place":["Padova, Italy, 35131"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Marzola","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Pola","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Frezza","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Argentieri","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5994-7634","authenticated-orcid":true,"given":"Federica","family":"Agosta","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7612-2050","authenticated-orcid":true,"given":"Antonella","family":"Ciancetta","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1075-3781","authenticated-orcid":true,"given":"Delia","family":"Preti","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3377-5107","authenticated-orcid":true,"given":"Salvatore","family":"Pacifico","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1947-2644","authenticated-orcid":true,"given":"Valentina","family":"Albanese","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7049-7576","authenticated-orcid":true,"given":"Giulio","family":"Meneguzzo","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4562-9550","authenticated-orcid":true,"given":"Davide","family":"Malfacini","sequence":"additional","affiliation":[{"name":"University of Padova , , Largo Meneghetti, 2 , ,","place":["Padova, Italy, 35131"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1360-202X","authenticated-orcid":true,"given":"Chiara","family":"Ruzza","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]},{"name":"Laboratory for Advanced Therapies (LTTA) , , Via Fossato di Mortara 70 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girolamo","family":"Calo\u0300","sequence":"additional","affiliation":[{"name":"University of Padova , , Largo Meneghetti, 2 , ,","place":["Padova, Italy, 35131"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Guerrini","sequence":"additional","affiliation":[{"name":"University of Ferrara , , Via Luigi Borsari 46 , ,","place":["Ferrara, Italy, 44121"]},{"name":"Laboratory for Advanced Therapies (LTTA) , , Via Fossato di Mortara 70 , ,","place":["Ferrara, Italy, 44121"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"6549","key":"2026081311090713900_cit1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and Structure\nof the Endogenous Agonist of Opioid Receptor-like ORL1 Receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"key":"2026081311090713900_cit2","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1126\/science.270.5237.792","article-title":"Orphanin FQ: A Neuropeptide That Activates an Opioidlike\nG Protein-Coupled Receptor","volume":"270","author":"Reinscheid","year":"1995","journal-title":"Science"},{"issue":"2","key":"2026081311090713900_cit3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/pr.114.009209","article-title":"Nociceptin\/Orphanin\nFQ Receptor Structure, Signaling, Ligands, Functions, and Interactions\nwith Opioid Systems","volume":"68","author":"Toll","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"2026081311090713900_cit4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/164_2018_198","article-title":"NOP-Targeted Peptide Ligands","volume":"254","author":"Preti","year":"2019","journal-title":"Handb Exp Pharmacol."},{"key":"2026081311090713900_cit5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI171172","article-title":"The Nociceptin\/Orphanin\nFQ Receptor Partial\nAgonist Sunobinop Promotes Non-REM Sleep in Rodents and Patients with\nInsomnia","volume":"134","author":"Whiteside","year":"2024","journal-title":"J. Clin. Invest."},{"key":"2026081311090713900_cit6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2214171120","article-title":"Activation of the\nNociceptin\/Orphanin-FQ Receptor Promotes NREM Sleep and EEG Slow Wave\nActivity","volume":"120","author":"Morairty","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"2026081311090713900_cit7","doi-asserted-by":"publisher","first-page":"PL23","DOI":"10.1016\/0024-3205(96)00261-5","article-title":"Orphanin FQ: Receptor Binding and\nAnalog Structure\nActivity Relationships in Rat Brain","volume":"59","author":"Dooley","year":"1996","journal-title":"Life Sci."},{"issue":"1","key":"2026081311090713900_cit8","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1016\/0014-2999(96)00563-8","article-title":"The Mouse\nVas Deferens: A Pharmacological Preparation Sensitive to Nociceptin","volume":"311","author":"Calo\u0300","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"2026081311090713900_cit9","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1021\/jm970011b","article-title":"Address and\nMessage\nSequences for the Nociceptin Receptor: A Structure\u2013Activity\nStudy of Nociceptin-(1\u201313)-peptide amide","volume":"40","author":"Guerrini","year":"1997","journal-title":"J. Med. Chem."},{"issue":"18","key":"2026081311090713900_cit10","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1021\/jm970805q","article-title":"Structure\u2013Activity Study of\nthe Nociceptin(1\u201313)-NH 2 N-Terminal Tetrapeptide and Discovery\nof a Nociceptin Receptor Antagonist","volume":"41","author":"Calo\u2019","year":"1998","journal-title":"J. Med.\nChem."},{"key":"2026081311090713900_cit11","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1021\/jm990075h","article-title":"Further Studies on Nociceptin-Related Peptides:\nDiscovery of a New Chemical Template with Antagonist Activity on the\nNociceptin Receptor","volume":"43","author":"Guerrini","year":"2000","journal-title":"J. Med. Chem."},{"issue":"23","key":"2026081311090713900_cit12","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1021\/jm010221v","article-title":"Structure\u2013Activity Studies of the Phe 4 Residue\nof Nociceptin(1\u201313)-NH 2: Identification of Highly Potent Agonists\nof the Nociceptin\/Orphanin FQ Receptor","volume":"44","author":"Guerrini","year":"2001","journal-title":"J. Med.\nChem."},{"issue":"6","key":"2026081311090713900_cit13","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/sj.bjp.0703169","article-title":"Characterization of [Nphe 1 ]nociceptin(1-13)NH 2 ,\na new selective nociceptin receptor antagonist","volume":"129","author":"Calo\u2019","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"2026081311090713900_cit14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00210-002-0548-8","article-title":"Pharmacological characterisation of [(pX)Phe 4 ]nociceptin(1-13)amide\nanalogues","volume":"365","author":"Bigoni","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"2026081311090713900_cit15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00210-002-0549-7","article-title":"Pharmacological\ncharacterisation of [(pX)Phe 4 ]nociceptin(1-13)NH\n2 analogues","volume":"365","author":"Rizzi","year":"2002","journal-title":"Naunyn-Schmiedeberg\u2019s Arch.\nPharmacol"},{"issue":"2","key":"2026081311090713900_cit16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1006\/bbrc.2000.3822","article-title":"Highly Potent\nNociceptin Analog Containing\nthe Arg-Lys Triple Repeat","volume":"278","author":"Okada","year":"2000","journal-title":"Biochem. Biophys.\nRes. Commun."},{"issue":"2","key":"2026081311090713900_cit17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/sj.bjp.0704706","article-title":"[Nphe1,Arg14,\nLys15]Nociceptin-NH2, a Novel\nPotent and Selective Antagonist of the Nociceptin\/Orphanin FQ Receptor","volume":"136","author":"Calo","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"2026081311090713900_cit18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1527-3458.2005.tb00264.x","article-title":"UFP-101, a\nPeptide Antagonist Selective for the Nociceptin\/Orphanin FQ Receptor","volume":"11","author":"Calo","year":"2005","journal-title":"CNS Drug Rev."},{"issue":"24","key":"2026081311090713900_cit19","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.1021\/jm0202021","article-title":"Novel, Potent ORL-1\nReceptor Agonist Peptides Containing \u03b1-Helix-Promoting Conformational\nConstraints","volume":"45","author":"Zhang","year":"2002","journal-title":"J. Med. Chem."},{"key":"2026081311090713900_cit20","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.peptides.2007.04.020","article-title":"In\nVitro and in Vivo Studies on UFP-112, a Novel Potent and Long Lasting\nAgonist Selective for the Nociceptin\/Orphanin FQ Receptor","volume":"28","author":"Rizzi","year":"2007","journal-title":"Peptides"},{"issue":"3","key":"2026081311090713900_cit21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1755-5949.2009.00107.x","article-title":"UFP-112 a Potent and\nLong-Lasting\nAgonist Selective for the Nociceptin\/Orphanin FQ Receptor","volume":"17","author":"Calo\u2019","year":"2011","journal-title":"CNS Neurosci Ther."},{"issue":"1","key":"2026081311090713900_cit22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic\nPeptides: Current Applications and Future Directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduction Targeted Ther."},{"key":"2026081311090713900_cit23","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/cbic.201500312","article-title":"Peptide Backbone\nComposition and\nProtease Susceptibility: Impact of Modification Type, Position, and\nTandem Substitution","volume":"17","author":"Werner","year":"2016","journal-title":"ChemBioChem"},{"issue":"6","key":"2026081311090713900_cit24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00210-009-0396-x","article-title":"Pharmacological profile of NOP receptors coupled with\ncalcium signaling via the chimeric protein G\u03b1qi5","volume":"379","author":"Camarda","year":"2009","journal-title":"Naunyn-Schmied Arch Pharmacol."},{"key":"2026081311090713900_cit25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132865","article-title":"Pharmacological\nProfile of Nociceptin\/Orphanin FQ Receptors\nInteracting with G-Proteins and \u03b2-Arrestins 2","volume":"10","author":"Malfacini","year":"2015","journal-title":"PLoS One"},{"key":"2026081311090713900_cit26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0028-3908(01)00048-X","article-title":"Influence of the Selective ORL1 Receptor Agonist, Ro64-6198,\non Rodent Neurological Function","volume":"41","author":"Higgins","year":"2001","journal-title":"Neuropharmacology"},{"issue":"1","key":"2026081311090713900_cit27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1213\/01.ane.0000250403.88649.51","article-title":"The Hypnotic,\nElectroencephalographic, and Antinociceptive Properties of Nonpeptide\nORL1 Receptor Agonists after Intravenous Injection in Rodents","volume":"104","author":"Byford","year":"2007","journal-title":"Anesth. Analg."},{"key":"2026081311090713900_cit28","doi-asserted-by":"publisher","first-page":"23448","DOI":"10.1021\/acs.jmedchem.5c02350","article-title":"Synthesis\nand Pharmacological Characterization of Nociceptin\/Orphanin FQ Dimeric\nLigands","volume":"68","author":"Albanese","year":"2025","journal-title":"J. Med. Chem."},{"issue":"11\u201312","key":"2026081311090713900_cit29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0014-827X(99)00108-1","article-title":"Structure\u2013activity\nstudies on nociceptin\/orphanin FQ: From full agonist, to partial agonist,\nto pure antagonist","volume":"54","author":"Salvadori","year":"1999","journal-title":"Farmaco"},{"key":"2026081311090713900_cit30","doi-asserted-by":"publisher","first-page":"8034","DOI":"10.1021\/acs.jcim.4c00499","article-title":"A Multi-Angle Approach to Predict\nPeptide-GPCR Complexes: The N\/OFQ-NOP System as a Successful AlphaFold\nApplication Case Study","volume":"64","author":"Ciancetta","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"2026081311090713900_cit31","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1039\/D4MD00747F","article-title":"Probing Non-Peptide\nAgonists Binding at the Human Nociceptin\/Orphanin FQ Receptor: A Molecular\nModelling Study","volume":"16","author":"Gozzi","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"W1","key":"2026081311090713900_cit32","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: Fully\nautomated protein\u2013ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"20","key":"2026081311090713900_cit33","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.2174\/0929867325666180111095458","article-title":"Nociceptin \/Orphanin\nFQ Peptide (NOP) Receptor Modulators: An Update in Structure-Activity\nRelationships","volume":"25","author":"Mustazza","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"2026081311090713900_cit34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1021\/bk-2013-1131.ch015","article-title":"Medicinal\nChemistry, Pharmacology, and Biological Actions of Peptide Ligands\nSelective for the Nociceptin\/Orphanin FQ Receptor","volume-title":"Research and Development of Opioid-Related LigandsACS Symposium\nSeries","author":"Calo\u2019","year":"2013"},{"key":"2026081311090713900_cit35","volume-title":"A Pharmacology Primer","author":"Kenakin","year":"2018","edition":"5th"},{"issue":"24","key":"2026081311090713900_cit36","doi-asserted-by":"publisher","first-page":"14163","DOI":"10.1074\/jbc.271.24.14163","article-title":"Structure-Activity\nRelationship Studies on the Novel Neuropeptide Orphanin FQ","volume":"271","author":"Reinscheid","year":"1996","journal-title":"J. Biol. Chem."},{"key":"2026081311090713900_cit37","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/0196-9781(96)00079-4","article-title":"Nociceptin in Vitro\nBiotransformation in Human Blood","volume":"17","author":"Yu","year":"1996","journal-title":"Peptides"},{"key":"2026081311090713900_cit38","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0196-9781(00)00228-X","article-title":"Nociceptin\/Orphanin\nFQ Metabolism\nand Bioactive Metabolites","volume":"21","author":"Terenius","year":"2000","journal-title":"Peptides"},{"issue":"1","key":"2026081311090713900_cit39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1046\/j.1471-4159.1997.68010354.x","article-title":"Nociceptin\/Orphanin\nFQ Metabolism: Role of Aminopeptidase and Endopeptidase 24.15","volume":"68","author":"Montiel","year":"1997","journal-title":"J. NeuroChem."},{"issue":"11","key":"2026081311090713900_cit40","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0006-2952(99)00259-2","article-title":"Effect\nof D-Amino Acid Substitution\non the Stability, the Secondary Structure, and the Activity of Membrane-Active\nPeptide","volume":"58","author":"Hong","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"2026081311090713900_cit41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature11085","article-title":"Structure\nof the Nociceptin\/Orphanin FQ Receptor in Complex with\na Peptide Mimetic","volume":"485","author":"Thompson","year":"2012","journal-title":"Nature"},{"issue":"2","key":"2026081311090713900_cit42","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the Entire Human Opioid Receptor Family","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"2026081311090713900_cit43","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/prot.24077","article-title":"Homology Modeling and Molecular Dynamics Simulations\nof the Active State of the Nociceptin Receptor Reveal New Insights\ninto Agonist Binding and Activation","volume":"80","author":"Daga","year":"2012","journal-title":"Proteins"},{"key":"2026081311090713900_cit44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/164_2018_200","article-title":"Pharmacological Assays for Investigating the NOP Receptor","volume":"254","author":"Malfacini","year":"2019","journal-title":"Handb Exp Pharmacol."},{"key":"2026081311090713900_cit45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejphar.2015.02.020","article-title":"Acute and Subchronic Antinociceptive Effects of Nociceptin\/Orphanin\nFQ Receptor Agonists Infused by Intrathecal Route in Rats","volume":"754","author":"Micheli","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"2026081311090713900_cit46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pain.2009.10.026","article-title":"Long-Lasting Antinociceptive\nSpinal Effects in Primates of the Novel Nociceptin\/Orphanin FQ Receptor\nAgonist UFP-112","volume":"148","author":"Hu","year":"2010","journal-title":"Pain"},{"key":"2026081311090713900_cit47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/bcp.70193","article-title":"Efficacy\nand Safety of a Selective Partial Agonist for Nociception\/Orphanin-FQ\nPeptide (NOP) Receptors in Patients with Insomnia Disorder","volume":"92","author":"Whiteside","year":"2026","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2026081311090713900_cit48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-1-62703-086-1_18","article-title":"Chimeric G\nProteins in Fluorimetric Calcium Assays:\nExperience with Opioid Receptors","volume":"937","author":"Camarda","year":"2013","journal-title":"Methods Mol.\nBiol."},{"key":"2026081311090713900_cit49","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.neuropharm.2016.02.003","article-title":"Beta-Arrestin\n2 Rather than G Protein Efficacy Determines the Anxiolytic-versus\nAntidepressant-like Effects of Nociceptin\/Orphanin FQ Receptor Ligands","volume":"105","author":"Asth","year":"2016","journal-title":"Neuropharmacology"},{"key":"2026081311090713900_cit50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/0976-500X.72351","article-title":"Improving\nBioscience Research Reporting: The ARRIVE Guidelines for Reporting\nAnimal Research","volume":"1","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"2026081311090713900_cit51","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/emboj\/16.8.1858","article-title":"Unrestrained Nociceptive Response and Disregulation of Hearing Ability\nin Mice Lacking the Nociceptin\/OrphaninFQ Receptor","volume":"16","author":"Nishi","year":"1997","journal-title":"EMBO J"},{"issue":"1","key":"2026081311090713900_cit52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0014-2999(02)01833-2","article-title":"Up-Regulation\nof ORL-1 Receptors in Spinal Tissue of Allodynic Rats after Sciatic\nNerve Injury","volume":"447","author":"Briscini","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"2026081311090713900_cit53","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1177\/0269881119864942","article-title":"Modulation of the NOP\nReceptor Signaling Affects Resilience to Acute Stress","volume":"33","author":"Holanda","year":"2019","journal-title":"J Psychopharmacol."},{"issue":"2","key":"2026081311090713900_cit54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/bjp.2008.96","article-title":"Neuropeptide\nS is a stimulatory anxiolytic agent: A behavioural study in mice","volume":"154","author":"Rizzi","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"2026081311090713900_cit55","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0160-5402(86)90038-0","article-title":"Intracerebroventricular Injections in Mice. Some Methodological\nRefinements","volume":"16","author":"Laursen","year":"1986","journal-title":"J. Pharmacol Methods"},{"key":"2026081311090713900_cit56","volume-title":"Molecular Operating\nEnvironment (MOE)","author":"Chemical Computing Group ULC.","year":"2023"},{"key":"2026081311090713900_cit57","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: A Web-Based Graphical\nUser Interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"2026081311090713900_cit58","doi-asserted-by":"publisher","first-page":"D370","DOI":"10.1093\/nar\/gkr703","article-title":"OPM Database\nand PPM Web Server: Resources for Positioning of Proteins in Membranes","volume":"40","author":"Lomize","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"2026081311090713900_cit59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005659","article-title":"OpenMM 7: Rapid Development\nof High Performance Algorithms for Molecular Dynamics","volume":"13","author":"Eastman","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"2026081311090713900_cit60","first-page":"98","article-title":"MDAnalysis:\nA Python Package for the Rapid Analysis of Molecular Dynamics Simulations","volume-title":"Proceedings Of The 15th Python In Science Conference; Proceedings\nOf The Python In Science Conference","author":"Gowers","year":"2016"},{"issue":"4","key":"2026081311090713900_cit61","doi-asserted-by":"publisher","first-page":"044130","DOI":"10.1063\/5.0014475","article-title":"Scalable Molecular Dynamics\non CPU and GPU Architectures\nwith NAMD","volume":"153","author":"Phillips","year":"2020","journal-title":"J. Chem. Phys."},{"issue":"1","key":"2026081311090713900_cit62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual Molecular Dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph"},{"issue":"4","key":"2026081311090713900_cit63","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1124\/pr.55.4.4","article-title":"International\nUnion of Pharmacology Committee on Receptor Nomenclature and Drug\nClassification. XXXVIII. Update on Terms and Symbols in Quantitative\nPharmacology","volume":"55","author":"Neubig","year":"2003","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"2026081311090713900_cit64","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1111\/bph.16177","article-title":"The\nConcise Guide to PHARMACOLOGY 2023\/24: G Protein-Coupled Receptors","volume":"180","author":"Alexander","year":"2023","journal-title":"Br. J. Pharmacol."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01281","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/15\/18977\/66238331\/acs.jmedchem.6c01281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/15\/18977\/66238331\/acs.jmedchem.6c01281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:27:02Z","timestamp":1786634822000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/15\/18977\/5231286\/Design-of-New-Potent-Selective-and-Long-Acting-NOP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":64,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,7,23]]},"published-print":{"date-parts":[[2026,8,13]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01281","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}